Ed Joyce | Director, IR |
Karen Zaderej | Chairman, President & CEO |
Peter Mariani | EVP & CFO |
Erick DeVinney | VP of Peripheral Nerve Science & Clinical Innovation |
Erin Fahey | SVB Leerink |
Frank Pinal | Jefferies |
Ross Osborn | Cantor Fitzgerald |
Dave Turkaly | JMP Securities |
Good day, ladies and gentlemen, and welcome to the AxoGen, Inc. Reports First Quarter Earnings Call. [Operator Instructions] At this time, it is my pleasure to turn the floor over to your host, Ed Joyce. Sir, the floor is yours.
Thank you, Dagmar, and good afternoon, everyone.